1,920
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Prevalence and molecular characterization of common thalassemia among people of reproductive age in the border area of Guangxi-Yunnan-Guizhou province in Southwestern China

, , , , , , , , , & show all

References

  • Birgens H, Ljung R. The thalassaemia syndromes. Scand J Clin Lab Invest. 2007;67(1):11–25.
  • Shafique F, Ali S, Almansouri T, et al. Thalassemia, a human blood disorder. Braz J Biol. 2021;83:e246062.
  • Martin M, Haines D. Clinical management of patients with thalassemia syndromes. Clin J Oncol Nurs. 2016;20(3):310–317.
  • Jiang F, Zuo L, Li J, et al. Evaluation of intervention strategy of thalassemia for couples of childbearing ages in centre of southern China. J Clin Lab Anal. 2021;35(10):e23990.
  • Ip HW, So CC. Diagnosis and prevention of thalassemia. Crit Rev Clin Lab Sci. 2013;50(6):125–141.
  • Li CK. New trend in the epidemiology of thalassaemia. Best Pract Res Clin Obstet Gynaecol. 2017;39:16–26.
  • Shang X, Peng Z, Ye Y, et al. Rapid targeted next-generation sequencing platform for molecular screening and clinical genotyping in subjects with hemoglobinopathies. EBioMedicine. 2017;23:150–159.
  • Xiong F, Sun M, Zhang X, et al. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010;78(2):139–148.
  • He S, Qin Q, Yi S, et al. Prevalence and genetic analysis of alpha- and beta-thalassemia in Baise region, a multi-ethnic region in southern China. Gene. 2017;619:71–75.
  • Pan HF, Long GF, Li Q, et al. Current status of thalassemia in minority populations in Guangxi, China. Clin Genet. 2007;71(5):419–426.
  • Long J, Pang W, Sun L, et al. Diagnosis of a family with the novel -alpha(21.9) thalassemia deletion. Hemoglobin. 2015;39(6):419–422.
  • Tang W, Zhang C, Lu F, et al. Spectrum of alpha-thalassemia and beta-thalassemia mutations in the Guilin region of southern China. Clin Biochem. 2015;48(16-17):1068–1072.
  • Gu H, Wang YX, Du MX, et al. Effectiveness of using mean corpuscular volume and mean corpuscular hemoglobin for beta-thalassemia carrier screening in the Guangdong population of China. Biomed Environ Sci. 2021;34(8):667–671.
  • He S, Li D, Lai Y, et al. Prenatal diagnosis of beta-thalassemia in Guangxi Zhuang autonomous region, China. Arch Gynecol Obstet. 2014;289(1):61–65.
  • Huang TL, Zhang TY, Song CY, et al. Gene mutation spectrum of thalassemia among children in Yunnan province. Front Pediatr. 2020;8:159.
  • Huang SW, Liu XM, Li GF, et al. Spectrum of beta-thalassemia mutations in Guizhou province, PR China, including first observation of codon 121 (GAA > TAA) in Chinese population. Clin Biochem. 2013;46(18):1865–1868.
  • Yamsri S, Sanchaisuriya K, Fucharoen G, et al. Prevention of severe thalassemia in northeast Thailand: 16 years of experience at a single university center. Prenat Diagn. 2010;30(6):540–546.
  • Rahim F, Kaikhaei B, Zandian K, et al. Co-inheritance of alpha-and beta-thalassemia in Khuzestan province, Iran. Hematology. 2008;13(1):59–64.
  • Wee YC, Tan KL, Kuldip K, et al. Alpha-thalassaemia in association with beta-thalassaemia patients in Malaysia: a study on the co-inheritance of both disorders. Community Genet. 2008;11(3):129–134.
  • Shang X, Xu X. Update in the genetics of thalassemia: what clinicians need to know. Best Pract Res Clin Obstet Gynaecol. 2017;39:3–15.
  • Mettananda S, Higgs DR. Molecular basis and genetic modifiers of thalassemia. Hematol Oncol Clin North Am. 2018;32(2):177–191.
  • Zhang H, Li C, Li J, et al. Next-generation sequencing improves molecular epidemiological characterization of thalassemia in Chenzhou region. P.R. China. J Clin Lab Anal. 2019;33(4):e22845.
  • He J, Song W, Yang J, et al. Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China. Genet Med. 2017;19(9):1022–1031.
  • Chen P, Yu X, Huang H, et al. Evaluation of Ion Torrent next-generation sequencing for thalassemia diagnosis. J Int Med Res. 2020;48(12):1–9.
  • Jiang F, Chen GL, Li J, et al. Pre gestational thalassemia screening in Mainland China: the first two years of a preventive program. Hemoglobin. 2017;41(4-6):248–253.
  • He P, Yang Y, Li R, et al. Prenatal control of Hb Bart's disease in mainland China: can we do better? Hemoglobin. 2014;38(6):435–439.
  • Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115(22):4331–4336.
  • Weatherall D. The inherited disorders of haemoglobin: an increasingly neglected global health burden. Indian J Med Res. 2011;134(4):493–497.
  • Lal A, Goldrich ML, Haines DA, et al. Heterogeneity of hemoglobin H disease in childhood. N Engl J Med. 2011;364(8):710–718.
  • Piga A, Perrotta S, Gamberini MR, et al. Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with beta-thalassemia. Blood. 2019;133(12):1279–1289.
  • Zhan W, Guo H, Hu S, et al. Comparison of cord blood hematological parameters among normal, alpha-thalassemia, and beta-thalassemia fetuses between 17 and 38 weeks of gestation. Sci Rep. 2021;11(1):3844.
  • Zhang J, He J, Mao X, et al. Haematological and electrophoretic characterisation of beta-thalassaemia in Yunnan province of Southwestern China. BMJ Open. 2017;7(1):e013367.